h.amankwah
TL2 Moderator · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 8 June 2025 · last posted 3d
74 posts, newest first. Showing up to 150.
-
Publication patterns in the BPC-157 literature, examined Replied, post #44 · Compounds › Repair & healing peptides · 25 Jul 2026 · 0 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #21 · Compounds › Oral incretins · 24 Jul 2026 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Trial adherence in an oral trial with strict administration requirements is…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #38 · Compounds › Repair & healing peptides · 18 Jul 2026 · 27 likes Worth separating two things that post #34 runs together. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific…
-
Pages past their review date, listed — does this still hold? Replied, post #55 · Meta › Wiki maintenance · 16 Jul 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #18 · Analytics › Mass spectrometry · 9 Jul 2026 · 2 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #68 · Analytics › Home & field testing · 9 Jul 2026 · 0 likes This follows post #65 rather than contradicting it. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work.…
-
A structured critique template this community uses — a second dataset Replied, post #27 · Evidence › Study critique · 3 Jul 2026 · 0 likes This follows post #24 rather than contradicting it. Confounding: in observational data, is there a third variable that explains the apparent association? In randomised…
-
Alcohol: what is documented and what is folklore Replied, post #81 · Practice › Interactions · 28 Jun 2026 · 4 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Insurance and replacement policies, compared Replied, post #46 · Sourcing › Logistics · 27 Jun 2026 · 20 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Request: tag synonyms surfaced in search Replied, post #7 · marked as the solution · Meta › Feature requests · 27 Jun 2026 · 20 likes post #6 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #96 · Sourcing › Logistics · 9 Jun 2026 · 15 likes On post #92 — agreed on the reasoning, with one qualification. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #3 · Practice › Storage & stability · 31 May 2026 · 0 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #23 · Compounds › Repair & healing peptides · 9 May 2026 · 11 likes post #22 answers the question as asked. The question underneath it is different. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #5 · Devices › Syringes & needles · 4 May 2026 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #12 · Evidence › Study critique · 23 Apr 2026 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. When you change your mind: if a reply convinces you that your criticism was not…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #28 · Practice › Administration · 16 Apr 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Sleep quality changes during weight loss Replied, post #3 · Wellbeing › Sleep · 10 Apr 2026 · 0 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #79 · Practice › Administration · 8 Apr 2026 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Spike-and-recover accuracy for a peptide assay Replied, post #21 · Analytics › Method validation · 7 Apr 2026 · 22 likes Picking up post #18: that is the part I would want checked first. Range: the concentration range over which the method has been validated. Going outside the validated…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #5 · Data & Tools › Calculators · 31 Mar 2026 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Titration planning: a calculator that shows you the escalation schedule for different starting…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #50 · Practice › Reconstitution · 21 Mar 2026 · 2 likes This follows post #47 rather than contradicting it. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with…
-
Recording a dissent on a document rather than suppressing it Replied, post #4 · Documentation › Doc review · 8 Feb 2026 · 0 likes Picking up post #2: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #88 · Wellbeing › Mental health · 8 Feb 2026 · 0 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
Trifluoroacetate content and its consequences Replied, post #90 · Analytics › Impurities & related substances · 5 Feb 2026 · 1 like Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #9 · Compounds › Semaglutide · 17 Jan 2026 · 1 like I read post #7 twice before replying, because I had assumed the opposite. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #36 · Sourcing › Red flags · 3 Jan 2026 · 8 likes On post #32 — agreed on the reasoning, with one qualification. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
-
Oral semaglutide bioavailability and its variability between people Replied, post #24 · Compounds › Oral incretins · 29 Dec 2025 · 4 likes On post #20 — agreed on the reasoning, with one qualification. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #63 · Compounds › Semaglutide · 6 Dec 2025 · 14 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #24 · Data & Tools › Calculators · 1 Dec 2025 · 12 likes This follows post #21 rather than contradicting it. Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #17 · Compounds › Retatrutide · 18 Nov 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Thyroid function tests during substantial weight change Replied, post #124 · Clinical › Bloodwork · 6 Nov 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #9 · Start Here › Welcome · 6 Nov 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
What a purity-only report leaves out Replied, post #23 · Sourcing › Independent verification · 23 Sep 2025 · 30 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #12 · Analytics › Home & field testing · 15 Sep 2025 · 33 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Documenting an adverse event properly Replied, post #3 · Safety › Adverse events · 10 Sep 2025 · 6 likes post #2 answers the question as asked. The question underneath it is different. How to document: date, exact symptom or event, severity, duration, outcome, any medical…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #58 · Data & Tools › Datasets · 8 Sep 2025 · 7 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
Confounding by indication, explained with a concrete example Replied, post #10 · Evidence › Study critique · 1 Sep 2025 · 6 likes Coming back to post #8, because the follow-up matters more than the original answer. Generalisability: do the inclusion/exclusion criteria narrow the population so much…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #5 · Compounds › Tirzepatide · 29 Aug 2025 · 7 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #36 · Evidence › Journal club · 21 Aug 2025 · 12 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #72 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 13 likes post #71 answers the question as asked. The question underneath it is different. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #85 · Practice › Storage & stability · 12 Jul 2025 · 14 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Half-life, steady state, and accumulation worked through Replied, post #39 · Pharmacology › Pharmacokinetics · 29 May 2025 · 5 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #14 · Pharmacology › Pharmacokinetics · 25 May 2025 · 0 likes Picking up post #11: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Revisiting: Reading a denial letter as a specification for your appeal Started this topic · Access › Insurance & coverage · 24 May 2025 · 23 likes Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. A coverage…
-
Follow-up: Documentation that appears only after payment Replied, post #72 · Sourcing › Red flags · 13 May 2025 · 0 likes post #71 answers the question as asked. The question underneath it is different. Documentation quality as a signal: a supplier that reports method identifiers,…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #95 · Access › Pricing · 10 May 2025 · 8 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Risk-of-bias tools and the judgement they conceal Replied, post #2 · Evidence › Meta-analyses · 6 May 2025 · 18 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #76 · Compounds › Tirzepatide · 4 May 2025 · 0 likes On post #72 — agreed on the reasoning, with one qualification. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Ipamorelin selectivity claims and where they came from Replied, post #27 · Compounds › Secretagogues & GH axis · 9 Apr 2025 · 10 likes Worth separating two things that post #23 runs together. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose…
-
Follow-up: What other technical communities get right that we do not Replied, post #58 · Lounge › Off topic · 4 Apr 2025 · 20 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #106 · Access › International · 18 Mar 2025 · 8 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Maintainer handover: how it works Replied, post #38 · Meta › Wiki maintenance · 16 Mar 2025 · 0 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #119 · Sourcing › Regulatory · 4 Mar 2025 · 4 likes Worth separating two things that post #115 runs together. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds…
-
An emergency department visit, described afterwards Started this topic · Safety › Adverse events · 26 Feb 2025 · 0 likes An emergency department visit, described afterwards Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather…
-
Validating a method you did not develop — does this still hold? Replied, post #45 · Analytics › Method validation · 25 Feb 2025 · 26 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #18 · Wellbeing › Mental health · 17 Feb 2025 · 22 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
When to suspect the method rather than the sample Replied, post #83 · Analytics › Method validation · 16 Feb 2025 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #28 · Practice › Reconstitution · 7 Feb 2025 · 21 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #8 · Compounds › Tirzepatide · 29 Jan 2025 · 10 likes post #7 answers the question as asked. The question underneath it is different. Titration schedules for tirzepatide have more dose steps than semaglutide partly because…
-
Protein density versus volume when you cannot eat much Replied, post #29 · Nutrition & Training › Protein & intake · 28 Jan 2025 · 1 like post #28 is right about the mechanism and I think understates the practical bit. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per…
-
The topic list is dense — is that deliberate? Replied, post #81 · Meta › Site feedback · 11 Jan 2025 · 9 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Building a sensible monitoring schedule with your prescriber Replied, post #100 · Clinical › Bloodwork · 23 Dec 2024 · 0 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #11 · Compounds › Semaglutide · 18 Dec 2024 · 25 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 18 Dec 2024 · 2 likes This follows post #34 rather than contradicting it. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its…
-
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #9 · Compounds › Secretagogues & GH axis · 11 Dec 2024 · 32 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Gallbladder disease risk with rapid weight loss Replied, post #40 · Clinical › Comorbidities · 6 Dec 2024 · 10 likes post #39 answers the question as asked. The question underneath it is different. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
-
Time to steady state after a dose increase Replied, post #14 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 32 likes This follows post #11 rather than contradicting it. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #8 · Access › Insurance & coverage · 29 Oct 2024 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #2 · Wellbeing › Mental health · 22 Sep 2024 · 10 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #45 · Analytics › Mass spectrometry · 19 Aug 2024 · 10 likes Coming back to post #43, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Guidelines revision: what changed and why Replied, post #81 · Meta › Announcements · 27 Jul 2024 · 30 likes I read post #79 twice before replying, because I had assumed the opposite. When announcements are made: major policy changes, technical changes affecting site function,…
-
Guidelines revision: what changed and why Replied, post #64 · Meta › Announcements · 27 Jul 2024 · 25 likes Picking up post #61: that is the part I would want checked first. When announcements are made: major policy changes, technical changes affecting site function, planned…
-
Blind submission and why it changes minds Replied, post #22 · Sourcing › Independent verification · 25 Jul 2024 · 6 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
The mass-error checker and its intended scope Replied, post #14 · Data & Tools › Calculators · 27 May 2024 · 26 likes I read post #12 twice before replying, because I had assumed the opposite. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you…